Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Beta3-adrenoceptor agonists reported by Asahi Chemical

Oct. 30, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

New ACAT inhibitors discovered at Mitsubishi Chemical

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Shaman issued U.S. patent for antidiabetic compounds

Oct. 28, 1997

Watson acquires Searle contraceptive products

Oct. 27, 1997

New antidiabetic agents from Boehringer Mannheim

Oct. 24, 1997

Major advance in thalassemia research reported

Oct. 24, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Viagra awarded priority review status by FDA

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...